Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study

Title
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
Authors
Keywords
Tocilizumab, SARS-CoV-2, COVID-19, Viral kinetics, Antibody responses, Anti-cytokine therapy, S-IgG, N-IgG
Journal
EBioMedicine
Volume 60, Issue -, Pages 102999
Publisher
Elsevier BV
Online
2020-09-16
DOI
10.1016/j.ebiom.2020.102999

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now